Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Kura Oncology, Inc.

Pharmaceutical Preparations · San Diego, CA, United States

  1. PrincipalsBrian T. PowlChief Commercial OfficerFrancis BurrowsChief Scientific OfficerKathleen FordChief Operating Officerand 6 more
  2. CompanyKura Oncology, Inc.San Diego, CA, United States
  3. Phone line+1 (858) 500-8800General business
Request a quote

Kura Oncology, Inc. is an SEC-registered Nasdaq-listed company (ticker KURA) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 9

Chief executive

Troy Edward WilsonPresident and CEO

Chair & board

Faheem HasnainDirector (Board)
Thomas MalleyDirector (Board)

Operations

Kathleen FordChief Operating Officer

Sales & commercial

Brian T. PowlChief Commercial Officer

Legal

Teresa Brophy BairChief Legal Officer
Everyone else on file (3)
Francis BurrowsChief Scientific Officer
Mollie LeoniChief Medical Officer
Thomas James DoyleSVP, Finance & Accounting

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Brian T. Powl — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Francis Burrows — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Kathleen Ford — Chief Operating Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Mollie Leoni — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers